Drug Study

Name of Drug | | Mechanism of Action | Indication | Adverse Effect | Special Consideration | Nursing Responsibility | Rationale | Generic Name:AcetylcysteineBrand Name:(Fluimucil)Classification:MucolyticAntidote | Dosage:200mgFrequency:Route:Oral (diluted in ½ glass of water) | Splits links in the mucoprotein contained in respiratory mucus secretion, decreasing the viscosity of the mucus. | Mucolytic adjuvant theraphy for abnormal, viscid or inspissated mucus secretion in acute and chronic bronchopulmonary disease (pneumonia, asthmatic bronchitis) | * Nausea * Stomatitis * Urticaria * Bronchospasm * Rhinnorhea | Hypersensitivity to acetycysteine, use caution and discontinue immediately if bronchospasm occur. | 1. Teach patient about proper coughing and deep breathing techniques2. Monitor rate, depth, rhythm, and type of respiration | * Administration of this drug increased volume of liquefied bronchial secretions so cough should be adequate to maintain open airway. * Bronchospasm may likely to occur thus need to stop the treatment | Generic Name:PregabalinBrand Name:(Lyrica)Classification:Analgesic | Dosage:75 mgFrequency:ODRoute:Oral | Binds to Alpha2- Delta sites in the nerve in the CNS which reduces the calcium influx into the cells and decrease the release of neurotransmitter into the synaptic cleft resulting into less stimulation of the nerve. | Management of acute pain. | * Dizziness * Vertigo * Tremors * Confusion * Constipation * Flatulence * Edema * Back and Chest pain * Loss of fertility | Hypersensitivity to Pregabalin, lactation, use caution with Diabetes, HF, pregnancy | 1. Pregabalin therapy should be stopped gradually over at least 1 week.2.Monitor patient closely for hypersensitivity. | * It decreases risk of seizure activity and avoid unpleasant symptoms such as diarrhea, headache, insomnia, and nausea. * Red skin, urticaria, rash, dyspnea, facial swelling, wheezingare some signs of